Harvard Bioscience, Inc. (HBIO)
8.435
+0.12
(+1.38%)
USD |
NASDAQ |
Oct 27, 16:00
8.435
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Market Cap : 38.40M for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 37.88M |
| October 23, 2026 | 37.47M |
| October 22, 2026 | 37.97M |
| October 21, 2026 | 38.65M |
| October 20, 2026 | 37.97M |
| October 19, 2026 | 36.83M |
| October 16, 2026 | 36.83M |
| October 15, 2026 | 37.83M |
| October 14, 2026 | 37.10M |
| October 13, 2026 | 37.65M |
| October 12, 2026 | 37.51M |
| October 09, 2026 | 37.51M |
| October 08, 2026 | 37.01M |
| October 07, 2026 | 38.69M |
| October 06, 2026 | 38.97M |
| October 05, 2026 | 38.69M |
| October 02, 2026 | 37.97M |
| October 01, 2026 | 37.01M |
| September 30, 2026 | 36.05M |
| September 29, 2026 | 36.24M |
| September 28, 2026 | 36.33M |
| September 25, 2026 | 36.24M |
| September 24, 2026 | 36.51M |
| September 23, 2026 | 36.65M |
| September 22, 2026 | 36.05M |
| Date | Value |
|---|---|
| September 21, 2026 | 36.42M |
| September 18, 2026 | 36.19M |
| September 17, 2026 | 36.56M |
| September 16, 2026 | 36.28M |
| September 15, 2026 | 36.42M |
| September 14, 2026 | 36.83M |
| September 11, 2026 | 36.56M |
| September 10, 2026 | 37.10M |
| September 09, 2026 | 36.19M |
| September 08, 2026 | 36.19M |
| September 04, 2026 | 36.51M |
| September 03, 2026 | 36.42M |
| September 02, 2026 | 37.33M |
| September 01, 2026 | 36.60M |
| August 31, 2026 | 36.92M |
| August 28, 2026 | 36.10M |
| August 27, 2026 | 35.96M |
| August 26, 2026 | 34.83M |
| August 25, 2026 | 34.51M |
| August 24, 2026 | 34.37M |
| August 21, 2026 | 34.05M |
| August 20, 2026 | 34.37M |
| August 19, 2026 | 32.23M |
| August 18, 2026 | 31.73M |
| August 17, 2026 | 29.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agilent Technologies, Inc. | 50.05B |
| Bio-Rad Laboratories, Inc. | 10.19B |
| Bruker Corp. | 9.254B |
| Danaher Corp. | 163.17B |
| Illumina, Inc. | 42.18B |
Market Cap Related Metrics
| PS Ratio | 0.4303 |
| PEG Ratio | -0.1143 |
| Price to Book Value | 5.176 |
| Price | 8.435 |
| Earnings Yield | -27.54% |
| PEGY Ratio | -0.1143 |
| Operating PE Ratio | 65.93 |